Pin Oak Investment Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-1,054
Closed -$9K – 427
2020
Q3
$9K Hold
1,054
– – 0.01% 313
2020
Q2
$13K Hold
1,054
– – 0.01% 267
2020
Q1
$9K Hold
1,054
– – 0.01% 306
2019
Q4
$10K Hold
1,054
– – 0.01% 324
2019
Q3
$7K Sell
1,054
-167
-14% -$1.28K 0.01% 358
2019
Q2
$11K Hold
1,221
– – 0.01% 347
2019
Q1
$19K Hold
1,221
– – 0.02% 261
2018
Q4
$19K Hold
1,221
– – 0.02% 251
2018
Q3
$26K Hold
1,221
– – 0.02% 239
2018
Q2
$30K Buy
1,221
+167
+16% +$3.41K 0.02% 231
2018
Q1
$18K Hold
1,054
– – 0.01% 281
2017
Q4
$20K Buy
+1,054
New +$15.9K 0.02% 278

Other funds holding TEVA

Pin Oak Investment Advisors's TEVA Position: Q4 2020 in Review

Pin Oak Investment Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2020, closing a stake of 1,054 shares — an estimated $9K sold.

Pin Oak Investment Advisors first reported a position in TEVA in Q4 2017 and held it in 12 quarters. The position peaked at $30K in Q2 2018. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2020.

  • Pin Oak Investment Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2020 after selling out during the quarter.
  • Pin Oak Investment Advisors sold 1,054 Teva Pharmaceutical Industries Limited shares in Q4 2020, an estimated $9K.
  • Pin Oak Investment Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q4 2017 and held it in 12 quarters.
  • Pin Oak Investment Advisors's Teva Pharmaceutical Industries Limited position peaked at $30K in Q2 2018.
  • 450 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2020.

Based on Pin Oak Investment Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.